« Back to Covid-19 Home Page

COVID-19 clinical support

The current category is Managing Co-morbidities during Covid-19 pandemic

Rheumatology and MSK

NICE COVID-19 Rapid guidance

British Society for Rheumatology advice on vaccination for those who are immunosuppressed

Following reports yesterday around the use of the Astra Zenica vaccine for immunosuppressed patients, the BSR want to confirm the JCVI position (as our guidance states) that this vaccine is considered safe for this patient group. More details: bit.ly/2XmOMK6

Urgent and Emergency Musculoskeletal Conditions Requiring Onward Referral

This updated guidance follows the specialist guidance document produced during the first phase of the coronavirus pandemic. The guidance supports primary and community care practitioners in recognising serious pathology which requires emergency or urgent referral to secondary care in a patient who present with new or worsening musculoskeletal (MSK) symptoms.

Guidance from the British Society for Rheumatology

Updated (20th November 2020) guidance for the management of patients with musculoskeletal and rheumatic conditions

An update to the clinical guide for the management of patients with musculoskeletal and rheumatic conditions who are already taking corticosteroids, or require initiation of oral/IV corticosteroids, or require a corticosteroid injection in the context of the COVID-19 pandemic has been published on the British Society of Rheumatology website. 

Guidance for self-management of bone, joint and muscle pain from Chartered Society of Physiotherapist

Leaflets available here: http://bit.ly/2XlYsEz